Submitted by Anonymous (not verified) on 13 November 2025 - 16:08
Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Date of authorisation: 26/07/2018, Revision: 18, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Date of authorisation: 26/07/2018, Revision: 18, Status: Authorised